Autres langues Aelis Farma

Actions

AELIS

FR0014007ZB4

Marché Fermé - Euronext Paris Autres places de cotation 10:29:32 24/04/2024			Varia. 5j.	Varia. 1 janv.
13 ^EUR	0,00 %		0,00 %	-0,76 %

19/04	Les nuages s'amoncellent sur les marchés
19/04	En Direct des Marchés : Schneider, L'Oréal, EssilorLuxottica, Sodexo, Believe, TSMC, Netflix...

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bolsa de Madrid: Las nubes se ciernen sobre los mercados	19/04
Aelis Farma Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder	18/04
Aelis Farma SA Announces the Last Patient, Last Visit in its Clinical Phase 2b Trial with AEF0117 for the Treatment of Cannabis Use Disorder	18/04
Bolsa de Madrid: Después de Semana Santa, algo va mal	03/04
Aelis Farma Reports Its 2023 Annual Financial Resultsand Confirms Its 2024 Outlook	02/04
Aelis Farma SA Reports Earnings Results for the Full Year Ended December 31, 2023	02/04
Aelis Farma Appoints Chief Corporate Development Officer	18/01
Aelis Farma Announces the Appointment of Arsène Guekam as Chief Corporate Development Officer	17/01
Aelis Farma Announces Completion of Patient Randomization for Phase 2B Study with Aef0117 for the Treatment of Cannabis Addiction	09/01
Bolsa de Madrid: ¿El Nasdaq no lo para nadie?	08/11
Aelis Farma Announces Positive Results of Non-Clinical Studies Required by Regulatory Agencies to Enter Its First Cb1-SSI, AEF0117, in Phase 3 Clinical Trial for the Treatment of Cannabis Use Disorder	07/11
Aelis Farma SA Reports Earnings Results for the Half Year Ended June 30, 2023	25/09/23
Bolsa de Madrid: La renta variable se queda sin combustible	25/09/23
Aelis Farma : le DG et cofondateur récompensé par ses pairs	29/08/23
Bolsa de Madrid: Cuidado con los cuchillos que caen	05/07/23
Aelis Farma : Inside Information / Other news releases	05/07/23
Data Safety Monitoring Board OKs Aelis Farma's Mid-stage Trial of Cannabis Addiction Drug	05/07/23
Aelis Farma Receives a Positive Recommendation From the DSMB to Continue, With No Modification to the Protocol, the Phase 2b Clinical Study With AEF0117 in Cannabis Addiction	05/07/23
Aelis Farma Announces the Presentation of New Preclinical Data on its Drug Candidate AEF0217 at the 2nd European Conference on Phelan-McDermid Syndrome	12/06/23
Aelis Farma SA Approves Transfer of Registered Office	25/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Aelis Farma

Actions

AELIS

FR0014007ZB4

Autres langues

Filtres